Evaluation of the effect of Mirena® contraceptive device in controlling abnormal uterine bleeding
Adequate treatment of abnormal uterine bleeding is mandatory because it affects the quality of women’s life adversely, as it is responsible for medical, sexual, social and psychological problems. The mode of treatment is either medical or surgical, and a lot of cases end with hysterectomy due to either failure of medical treatment or severe side effects. Mirena® contraceptive device has been tested as a form of medical treatment to control abnormal uterine bleeding. The current study was aimed to investigate the role of Mirena® contraceptive device among Iraqi women with abnormal uterine bleeding after being followed up in comparison with another mode of conventional treatment. The first group included 45 women who were treated using the IUCD Mirena® and served as a study group, whereas the second group included 45 age-matched women who were treated with medical treatment other than Mirena® IUCD and served as a control group. Al-Diwaniyah province, Iraq. The study lasted for four years; it started in January 2014 and ended in January 2018. The results of this study revealed that the control of bleeding was successful in 32 (71.1%), 42 (93.3%), 42 (93.3%) and 42 (93.3%) of patients following first, second, third and fourth year of follow up in study group compared to 23 (51.1%), 27 (60.0%), 27 (60.0%) and 27 (60.0%) of patients in the control groups. The rate of hysterectomy was significantly lower in the study group than in control group, 8.9% versus 46.7%, respectively (P<0.001). The use of Mirena® was able to reduce the rate of hysterectomy by 0.89 % (Odds ratio of 0.11; 95% confidence interval of 0.03-0.36).
Article Level Metrics
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.